168 related articles for article (PubMed ID: 8577050)
1. [Farber's lipogranulomatosis].
Koga M
Nihon Rinsho; 1995 Dec; 53(12):3009-13. PubMed ID: 8577050
[TBL] [Abstract][Full Text] [Related]
2. [Farber disease [Farber lipogranulomatosis], acid ceramidase deficiency].
Koga M
Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):389-93. PubMed ID: 9645089
[No Abstract] [Full Text] [Related]
3. [A case of Farber's disease--histochemical, electron microscopic and biochemical studies].
Hamanaka S; Hara A; Otsuka F
Nihon Hifuka Gakkai Zasshi; 1991 May; 101(6):629-34. PubMed ID: 1920894
[TBL] [Abstract][Full Text] [Related]
4. Neurodegenerative course in ceramidase deficiency (Farber disease) correlates with the residual lysosomal ceramide turnover in cultured living patient cells.
Levade T; Moser HW; Fensom AH; Harzer K; Moser AB; Salvayre R
J Neurol Sci; 1995 Dec; 134(1-2):108-14. PubMed ID: 8747852
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities of lysosomes in human diploid fibroblasts from patients with Farber's disease.
Chen WW; Decker GL
Biochim Biophys Acta; 1982 Oct; 718(2):185-92. PubMed ID: 6814495
[TBL] [Abstract][Full Text] [Related]
6. [Farber disease: a cause of hoarseness of the voice in children].
el Sharkawy L; Abdallah H; Marzouk S
Rev Laryngol Otol Rhinol (Bord); 2000; 121(4):261-5. PubMed ID: 11233710
[TBL] [Abstract][Full Text] [Related]
7. [The cherry-red spot is an early sign of Farber's lipogranulomatosis].
Guseva MR; Pavliuk EIu
Vestn Oftalmol; 2008; 124(3):51-3. PubMed ID: 18589658
[No Abstract] [Full Text] [Related]
8. Farber's disease (lysosomal acid ceramidase deficiency).
Jameson RA; Holt PJ; Keen JH
Ann Rheum Dis; 1987 Jul; 46(7):559-61. PubMed ID: 3662645
[TBL] [Abstract][Full Text] [Related]
9. An autopsy case of Farber's lipogranulomatosis in a Japanese boy with gastrointestinal involvement.
Koga M; Ishihara T; Uchino F; Fujiwaki T
Acta Pathol Jpn; 1992 Jan; 42(1):42-8. PubMed ID: 1557987
[TBL] [Abstract][Full Text] [Related]
10. [Farber's lipogranulomatosis. Apropos of a case].
Palcoux JB; Desvignes V; Malpuech G; Charbonne F; Kantelip B; Raynaud EJ
Arch Fr Pediatr; 1985; 42(7):535-6. PubMed ID: 3936449
[TBL] [Abstract][Full Text] [Related]
11. Farber's lipogranulomatosis: ceramidase deficiency and prolonged survival in three relatives.
Pavone L; Moser HW; Mollica F; Reitano C; Durand P
Johns Hopkins Med J; 1980 Nov; 147(5):193-6. PubMed ID: 7441940
[No Abstract] [Full Text] [Related]
12. Sulfatide and sphingomyelin loading of living cells as tools for the study of ceramide turnover by lysosomal ceramidase--implications for the diagnosis of Farber disease.
Levade T; Tempesta MC; Moser HW; Fensom AH; Harzer K; Moser AB; Salvayre R
Biochem Mol Med; 1995 Apr; 54(2):117-25. PubMed ID: 8581356
[TBL] [Abstract][Full Text] [Related]
13. [Disseminated lipogranulomatosis (Farber disease) with hydrops fetalis].
Schäfer A; Harzer K; Kattner E; Schäfer HJ; Stoltenburg G; Lietz H
Pathologe; 1996 Mar; 17(2):145-9. PubMed ID: 8650144
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of ceramide-containing endocytotic vesicles in human diploid fibroblasts.
Sutrina SL; Chen WW
J Biol Chem; 1982 Mar; 257(6):3039-44. PubMed ID: 7061463
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow involvement and obstructive jaundice in Farber lipogranulomatosis: clinical and autopsy report of a new case.
Nowaczyk MJ; Feigenbaum A; Silver MM; Callahan J; Levin A; Jay V
J Inherit Metab Dis; 1996; 19(5):655-60. PubMed ID: 8892023
[TBL] [Abstract][Full Text] [Related]
16. Insertional mutagenesis of the mouse acid ceramidase gene leads to early embryonic lethality in homozygotes and progressive lipid storage disease in heterozygotes.
Li CM; Park JH; Simonaro CM; He X; Gordon RE; Friedman AH; Ehleiter D; Paris F; Manova K; Hepbildikler S; Fuks Z; Sandhoff K; Kolesnick R; Schuchman EH
Genomics; 2002 Feb; 79(2):218-24. PubMed ID: 11829492
[TBL] [Abstract][Full Text] [Related]
17. A case of Farber disease.
Fujiwaki T; Hamanaka S; Koga M; Ishihara T; Nishikomori R; Kinoshita E; Furusho K
Acta Paediatr Jpn; 1992 Feb; 34(1):72-9. PubMed ID: 1580156
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of acid ceramidase deficiency in patients with Farber disease.
Bär J; Linke T; Ferlinz K; Neumann U; Schuchman EH; Sandhoff K
Hum Mutat; 2001 Mar; 17(3):199-209. PubMed ID: 11241842
[TBL] [Abstract][Full Text] [Related]
19. A case of lipogranulomatosis Farber: some clinical and ultrastructural aspects.
Burck U; Moser HW; Goebel HH; Grüttner R; Held KR
Eur J Pediatr; 1985 Jan; 143(3):203-8. PubMed ID: 3987715
[TBL] [Abstract][Full Text] [Related]
20. Farber's disease: a fine structural study.
Abenoza P; Sibley RK
Ultrastruct Pathol; 1987; 11(4):397-403. PubMed ID: 3113021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
